ATLANTA, April 16, 2018 -- UPS (NYSE:UPS) will announce its 2018 first-quarter results on Thursday, April 26, 2018, at approximately 7 a.m. Eastern Time.
At 8:30 a.m. ET, UPS Chairman and Chief Executive Officer David Abney and Chief Financial Officer Richard Peretz will lead an investor conference call. This call will be open to reporters and the public via a live Webcast.
To listen to the live Webcast, go to http://www.investors.ups.com and click on Earnings Webcast. The Webcast audio will remain accessible on the Investor Relations Website for a limited time following the call.
# # #
Kyle Peterson 404-828-4626 [email protected]


Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
How Marco Pharma International Preserves German Homeopathic Traditions in America 



